Full Breakdown
FDA Issues Nationwide Recall of Over 4.3 Million Toothpaste Tubes
By Drooid · · How we work
Recall Overview
The U.S. Food and Drug Administration has announced 17 voluntary nationwide recalls affecting a range of toothpaste products marketed to children and adults. The agency cited “current good manufacturing practice deviations” but did not specify the exact nature of the problem. The recall was initiated in September after Pritam International Private Limited reported the issue to federal authorities.
Affected Brands and Product Types
The recall includes character-themed children’s lines such as Brush Buddies Barbie and Hot Wheels, as well as Crayola “Silly Scents” bubble-gum, watermelon and strawberry flavors, and My Little Pony bubble-gum toothpaste. Adult-oriented items span vanilla, mint chocolate chip, cookies ’n cream, chocolate ice-cream, mint whitening, and cavity-protection formulations. Two evo products marketed for whitening and sensitivity and two ARU toothpastes aimed at gum health and cavity protection are also covered.
Regulatory Classification and Health Implications
The FDA classified the recall as Class II, indicating that use of or exposure to the products may cause temporary or medically reversible health effects, while the likelihood of serious adverse outcomes is considered remote. No specific health incidents have been reported in the agency’s notice.
Companies Involved and Distribution Details
Pritam International Private Limited, the manufacturer, initiated the recall, and the products were distributed by Ashtel Studios Inc. of Ontario, California. The recalled tubes were shipped nationwide, with expiration dates ranging from November 2026 through June 2028.
Consumer Guidance
Consumers who possess any of the listed toothpaste tubes should stop using them immediately and follow the FDA’s recall instructions, which include returning the products to the point of purchase for a refund or contacting the manufacturer for disposal guidance. Retailers have been advised to remove the affected items from shelves. The FDA has not provided further comment on the underlying manufacturing issue.